medigraphic.com

2014, Number S1

<< Back Next >>

Rev Mex Anest 2014; 37 (S1)

Current status of central venous catéter in anesthesiology

Sánchez-Arzate KI, Molina-Méndez FJ

Language: Spanish
References: 38
Page: 138-145
PDF size: 177.08 Kb.


Text Extraction

No abstract


REFERENCES

  1. Waghorn DJ. Intravascular device-associated systemic infections: a 2 year analysis of cases in a district general hospital. J Hosp Infect. 1994;28:91-101.

  2. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123-1133.

  3. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134:172-178.

  4. Monet X, Teboul J-L. Passive leg raising. Intensive Care Med. 2008;34:659-663.

  5. Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013;110:333-346.

  6. Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev. 2012;3:CD004084.

  7. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012;40:2479-2485.

  8. Kellum JA. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2.

  9. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65:S1-64.

  10. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792-801.

  11. Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PloS One. 2012;7:e44277.

  12. National Institute for Health and Care Excellence. Guidance on the use of ultrasound locating devices for placing central venous catheters. TA49. 2002. http://guidance.nice.org.uk/TA49.

  13. Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:361.

  14. Lamperti M, Bodenham AR, Pittiruti M, et al. International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med. 2012;38:1105-1117.

  15. Sharma A, Bodenham AR, Mallick A. Ultrasound-guided infraclavicular axillary vein cannulation for central venous access. Br J Anaesth. 2004;93:188-192.

  16. Fragou M, Gravvanis A, Dimitriou V, Papalois A, Kouraklis G, Karabibis A, et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med. 2011;39:1607-1612.

  17. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11:71-80.

  18. Albrecht K, Nave H, Breitmeier D, Panning B, Troger HD. Applied anatomy of the superior vena cava-the carina as a landmark to guide central venous catheter placement. Br J Anaesth. 2004;92:75-77.

  19. Bion J, Richardson A, Hibbert P, Beer J, Abrusci T, McCutcheon M, et al. “Matching Michigan”: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Safe. 2013;22:110-123.

  20. Hopkins S, Shaw K, Simpson L. English national point prevalence survey on healthcare associated infections and antimicrobial use, 2011: preliminary data. Health Protection Agency, 2012. www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1317134304594.

  21. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.

  22. Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WSC, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2013;6:CD007878.

  23. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. epic3 National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. 2013. www.uwl.ac.uk/sites/default/files/Academic-schools/College-of-Nursing- Midwifery-and-Healthcare/Web/Epic3/epic3_Consultation_Draft.pdf.

  24. Dezfulian C, Lavelle J, Nallamothu BK, Kaufman SR, Saint S. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Crit Care Med. 2003;31:2385-2390.

  25. Van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev. 2007;1:CD003295.

  26. Snaterse M, Ruger W, Scholte Op Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75:1-11.

  27. Webster J, Gillies D, O’Riordan E, Sherriff KL, Rickard CM. Gauze and tape andtransparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev. 2011;11:CD003827.

  28. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med. 1997;25:1417-1424.

  29. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-2732.

  30. Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol. 2009;27:4858-4864.

  31. Rooden CJ, Tesselaar ME, Osanto S, Rosendaal FR, Huisman MV. Deep vein thrombosis associated with central venous catheters-a review. J Thromb Haemostas. 2005;3:2409-2419.

  32. Akl EA, Vasireddi SR, Gunukula S, Yosuico VED, Barba M, Sperati F, et al. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev. 2011;4:CD006468.

  33. Kirkpatrick A, Rathbun S, Whitsett T, Raskob G. Prevention of central venous catheter-associated thrombosis: a meta-analysis. Am J Med. 2007;120:901e1-13.

  34. Van Miert C, Hill R, Jones L. Interventions for restoring patency of occluded central venous catheter lumens. Cochrane Database Syst Rev. 2012;4:CD007119.

  35. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58:323-346.

  36. Chopra V, Anand S, Hickner A, Buist M, Rogers MAM, Saint S, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382:311-325.

  37. Pikwer A, Akeson J, Lindgren S. Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia. 2012;67:65-71.

  38. Chopra V, Anand S, Krein SL, Chenoweth C, Saint S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med. 2012;125:733-741.




2020     |     www.medigraphic.com